XML 58 R21.htm IDEA: XBRL DOCUMENT v3.20.1
RESTATEMENT (Tables)
3 Months Ended
Mar. 31, 2019
Accounting Changes and Error Corrections [Abstract]  
Summary of Restatements
Consolidated Balance Sheet as of March 31, 2019:
(In thousands)
As Originally Reported
 
Adjustments
 
As Restated
ASSETS
 
 
 
 
 
Current assets:
 
 
 
 
 
   Cash and cash equivalents
$
32,415

 
$

 
$
32,415

   Short term investments
40,885

 

 
40,885

   Trade accounts receivable, net
4,931

 
38

 
4,969

   Inventories, net
5,598

 

 
5,598

   Prepaid expenses and other current assets
1,411

 
38

 
1,449

     Total current assets
85,240

 
76

 
85,316

Property and equipment, net
6,031

 

 
6,031

Intangibles
190

 

 
190

Deposits
80

 

 
80

Other assets
162

 
77

 
239

     Total assets
$
91,703

 
$
153

 
$
91,856

 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
Current liabilities:
 
 
 
 
 
   Accounts payable
$
1,504

 
$

 
$
1,504

   Accrued expenses and other liabilities
5,460

 
127

 
5,587

Joint and several payroll tax liability

 
1,014

 
1,014

Accrued severance and related
511

 

 
511

     Total current liabilities
7,475

 
1,141

 
8,616

Related party note payable
140

 

 
140

Long-term portion of operating lease liabilities
75

 

 
75

Other long-term liabilities

 
194

 
194

   Total liabilities
7,690

 
1,335

 
9,025

STOCKHOLDERS' EQUITY
 
 
 
 
 
Common stock, $0.001 par value; 75,000,000 shares authorized; 34,033,255 issued and 33,891,255 outstanding
34

 

 
34

Additional paid-in capital
53,147

 
1,035

 
54,182

Retained earnings
30,832

 
(2,217
)
 
28,615

   Total stockholders’ equity
84,013

 
(1,182
)
 
82,831

     Total liabilities and stockholders’ equity
$
91,703

 
$
153

 
$
91,856




Consolidated Statement of Operations for the three months ended March 31, 2019:
(In thousands)
As Originally Reported
 
Adjustments
 
As Restated
Sales
$
5,823

 
$
(194
)
 
$
5,629

Cost of sales
2,103

 
(37
)
 
2,066

Gross profit
3,720

 
(157
)
 
3,563

Other costs and expenses:
 
 
 
 
 
Research and development
810

 
(80
)
 
730

Professional services
1,791

 
327

 
2,118

Salaries and related costs
3,221

 
267

 
3,488

Selling, general and administrative
3,101

 
(144
)
 
2,957

Total other costs and expenses
8,923

 
370

 
9,293

Loss from operations
(5,203
)
 
(527
)
 
(5,730
)
Interest income
423

 

 
423

Other losses
(25
)
 
(270
)
 
(295
)
Total other losses, net
398

 
(270
)
 
128

Loss from continuing operations before income taxes
(4,805
)
 
(797
)
 
(5,602
)
Income tax (benefit) expense
(124
)
 
130

 
6

Net loss
$
(4,681
)
 
$
(927
)
 
$
(5,608
)
 
 
 
 
 
 
Loss per share
 
 
 
 
 
Basic and Diluted
$
(0.14
)
 
$
(0.03
)
 
$
(0.17
)
 
 
 
 
 
 
Weighted average number of shares outstanding basic and diluted
33,343

 
33,343

 
33,343